Medicus Pharma has filed a clinical design with the United Arab Emirates Department of Health aimed at non-invasively treating Basal Cell Carcinoma (BCC), a type of skin cancer. The study is set to evaluate the effectiveness of two dose levels of D-MNA in comparison to a placebo control. In the initial study, known as SKNJCT-001,...
